A decrease of CD4+ T and CD8+ T cells was found in the context of COVID-19, and lymphopenia has been implicated as a risk factor for ARDS and mortality, suggesting that the adaptive immune system in the severe infection subgroup was less activated [44,61,62]. Here, CD4 is linked to COVID-19.